article thumbnail

Navigating the regulatory challenge of PFAS for pharmaceutical manufacturers

European Pharmaceutical Review

This poses a significant challenge for pharmaceutical manufacturers, not least because of the technical challenges related to operations, supply chain and the environment. This article explores the potential impact of the proposal and considers how manufacturers can ensure the safety and reliability of their products.

article thumbnail

Transforming pharmaceutical manufacturing: The AI revolution

European Pharmaceutical Review

Revolutionising quality control In the backdrop of stringent quality standards and regulatory demands inherent to pharmaceutical manufacturing, the addition of AI technologies introduce a paradigm shift. Figure 1 : adapted from Saha, G. Tuijin Jishu/Journal of Propulsion Technology, 44(3), 1384-1392.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: FDA is still struggling with a lack of inspectors, but doesn’t have a plan, watchdog finds

STAT

In the wake of the Covid-19 pandemic, the Food and Drug Administration continues to struggle with a lack of investigators needed to inspect domestic and foreign pharmaceutical manufacturing plants and has not yet developed a plan to keep needed staff, a U.S. government watchdog found.

article thumbnail

FlyPharma Europe, Vienna – 2023 conference officially launched

Pharma Times

FlyPharma Europe chose Vienna for its latest conference due to the growing presence of Austrian biotechnology and pharmaceutical manufacturing

article thumbnail

What Pharmaceutical Manufacturers Value Most from a Hub

Drug Channels

Based on CareMetx research, he outlines the key factors that drug manufacturers value in their hub partners. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. Learn more by downloading CareMetx’s full report: The Evolving Landscape of Digital Healthcare Hubs. Read on for Nasir’s insights. d/b/a Drug Channels Institute.

article thumbnail

How CDMOs Can Help with Regulatory Challenges

Drug Patent Watch

Quality Documentation and Manufacturing Expertise CDMOs are experienced in generating high-quality documentation required for regulatory submissions and have extensive expertise in drug development and manufacturing. 2023, November 17). 2023, October 12). link] UPM Pharmaceuticals. UPM Pharmaceuticals.

article thumbnail

Glance in the future: Explore innovative solutions at PHARMAP 2023

Express Pharma

PHARMAP 2023 gathered pharma companies, CMOs and CDMOs, governmental bodies to exchange experience in digital transformation and discuss innovative solutions and business practices. The next edition of the Pharmaceutical Manufacturing and Packaging Congress 2024 is going to take place on 22-23, April, in Amsterdam, the Netherlands.